Investors :: Carrick Therapeutics, Inc.

Latest News

View all news

Sep 23, 2024

Carrick Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT7439 (CDK12/13 Inhibitor)

Read more

Jun 5, 2024

Carrick Therapeutics Establishes New Headquarters in Boston, Massachusetts

Read more

Feb 14, 2024

Carrick Therapeutics Announces First Patient Dosed in Phase 1b/2 Clinical Trial of Samuraciclib in Combination with Vepdegestrant in Patients with Advanced Breast Cancer

Read more

View all news

Email Alerts

Stay informed and receive company updates straight to your inbox.

Sign up today

IR Contacts

Headquarters

Carrick Therapeutics, Inc.

hello@carricktherapeutics.com